Do β-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink

Georgina Nakafero,Mamas A Mamas,Michael Doherty,Abhishek Abhishek,Christian Mallen,Weiya Zhang,Ana Valdes,Matthew Grainge,Nick Townsend

doi:10.1136/bmjopen-2019-032050

Do β-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink

Georgina Nakafero, Mamas A Mamas + Show 7 more

Open Access

https://doi.org/10.1136/bmjopen-2019-032050

Copy DOI

Journal: BMJ Open	Publication Date: Aug 1, 2019
Citations: 2	License type: open-access

Affiliation: Keele University, University of Nottingham, Nottingham Biomedical Research Centre, University of Bath

#Β-blocker Prescription #Knee Osteoarthritis + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

IntroductionTo investigate if β-adrenoreceptor blocking drug (β-blocker) prescription reduces the risk of knee or hip osteoarthritis, total joint replacement and analgesic prescription.SettingPrimary care.Methods and analysisThis is a cohort study using...

Full Text